Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (4)

1

Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib

enthalten in: Expert review of hematology | 2017

von Bjørn, M. | Hasselbalch, H.

2

Interferon in polycythemia vera and related neoplasms. Can it become the treatment of choice without a randomized trial?

enthalten in: Expert review of hematology | 2015

von Hasselbalch, H. | Silver, R.

3

Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis

enthalten in: Expert review of hematology | 2013

von Silver, R. | Kiladjian, J. | Hasselbalch, H.

4

A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms

enthalten in: Expert review of hematology | 2011

von Hasselbalch, H.

1
[1]